ARPA-H, part of HHS, has earmarked up to $142 million for 10 research projects building the tools, data, and infrastructure needed to tackle treatment resistance.

Allogeneic cell therapies are advancing in clinical trials, requiring oncologists and pathologists to understand the ...

Our faces don’t just distinguish us from other people, but other species as well. Neanderthals bore stout jaws and broad noses, their features jutting forward like cliffs of bone. Chimpanzees, our ...

BEIJING -- A team of Chinese scientists, in collaboration with international researchers, has achieved a breakthrough in ...

Technology can be harnessed to design novel and enhanced molecules that address challenges in biotechnology or medicine.

Today, genomics is saving countless lives and even entire species, thanks in large part to a commitment to collaborative and ...

During his 36-year career at Cancer Center, Michael Emerman, PhD, made fundamental discoveries about HIV, the retrovirus that causes AIDS. He co-founded the field of paleovirology and considers ...

The law books record it as State of Tennessee v. John T. Scopes. History remembers it as the “ Monkey Trial .” The case ...

When people think of DNA, they usually think of genes, the parts that code for proteins and drive inherited traits. But there ...

PROTEUS, a system designed to harness “directed evolution,” can speed the process up by years, or even decades.

Cancer does not develop overnight. It can take decades for cancer‐promoting changes in the genome to eventually lead to the ...

The discovery may explain why cutting edge CAR T-cell therapy has managed to revolutionized treatment for blood cancer but ...